Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Ixazomib is part of an all-oral treatment regimen. When used in combination with···【more】
Release date：2026-01-07Recommended：282
On September 9, 2015, Cambridge, Massachusetts, USA, and Osaka, Japan, announced···【more】
Release date：2026-01-07Recommended：237
The U.S. Food and Drug Administration (FDA) approved ixazomib today for use in c···【more】
Release date：2026-01-07Recommended：244
Ivosidenib is available only with a doctor's prescription.Important Precauti···【more】
Release date：2026-01-07Recommended：316
KRAS G12C mutation in non-small cell lung cancer and colorectal cancer【more】
Release date：2026-01-06Recommended：147
Larotrectinib is indicated for the treatment of adult and pediatric patients wit···【more】
Release date：2026-01-06Recommended：174
Non-small cell lung cancer【more】
Release date：2026-01-06Recommended：186
Gilteritinib is suitable for Leukemia.【more】
Release date：2026-01-06Recommended：155
Capmatinib is indicated for the treatment of adult patients with metastatic non-···【more】
Release date：2026-01-06Recommended：273
Treatment of refractory relapsed multiple myeloma and certain types of diffuse l···【more】
Release date：2026-01-06Recommended：228
It is indicated for patients with susceptible isocitrate dehydrogenase-1 (IDH1) ···【more】
Release date：2026-01-06Recommended：199
Exkivity is suitable for specific non-small cell lung cancer(NSCLC).【more】
Release date：2026-01-06Recommended：193
Telegram name: Vira
Name: LUCIUS
No.:0085253923643
